Basic Information
Basic information for AC087473.1-202-12aa
Peptide Name AC087473.1-202-12aa
Genome Position chr15:38141771-38141806[-]
Species Human
Peptide Sequence MLQLKDTDWQIG
Peptide Length 12
Unique No (LINC01821-203-12aa,AC087473.1-201-12aa,AC019322.4-201-12aa-2,AC068448.1-201-12aa-2,AC091074.2-201-12aa,AC092445.1-201-12aa,LINC00662-233-12aa-2,AL136419.3-201-12aa,LINC00662-249-12aa-2,AP005901.5-201-12aa)
Grand Average of Hydropathicity -0.4917
Relative Molecular Mass 1645.86
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000259380;AC087473.1
Transcript ID/Name ENST00000561161;AC087473.1-202
Transcript Length 3487
Coding Ability 0.3725
DNA Sequence Corresponding to Peptide ATGCTCCAATTAAAAGACACAGACTGGCAAATTGGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :